Cardiac Involvement in Patients With Limb-Girdle Muscular Dystrophy Type 2 and Becker Muscular Dystrophy | Cardiology | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
1.
Bushby  KM Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies.  Neuromuscul Disord 1995;5 (1) 71- 74PubMedGoogle Scholar
2.
Nigro  GComi  LIPolitano  LNigro  G Cardiomyopathies associated with muscular dystrophies. Nogueira  IDavis  K Myology. 3rd ed. New York, NY McGraw-Hill2007;1239- 1300Google Scholar
3.
Merlini  LMazzone  ESSolari  AMorandi  L Reliability of hand-held dynamometry in spinal muscular atrophy.  Muscle Nerve 2002;26 (1) 64- 70PubMedGoogle Scholar
4.
Sveen  MLSchwartz  MVissing  J High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark.  Ann Neurol 2006;59 (5) 808- 815PubMedGoogle Scholar
5.
Lang  RMBierig  MDevereux  RB  et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography, Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.  J Am Soc Echocardiogr 2005;18 (12) 1440- 1463PubMedGoogle Scholar
6.
Nielsen  OWHilden  JLarsen  CTHansen  JF Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk.  Heart 2001;86 (2) 172- 178PubMedGoogle Scholar
7.
Nigro  GComi  LIPolitano  L  et al.  Evaluation of the cardiomyopathy in Becker muscular dystrophy.  Muscle Nerve 1995;18 (3) 283- 291PubMedGoogle Scholar
8.
Bushby  KMuntoni  FBourke  JP 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy.  Neuromuscul Disord 2003;13 (2) 166- 172PubMedGoogle Scholar
9.
Fougerousse  FAnderson  LVDelezoide  ALSuel  LDurand  MBeckmann  JS Calpain3 expression during human cardiogenesis.  Neuromuscul Disord 2000;10 (4-5) 251- 256PubMedGoogle Scholar
10.
Walter  MCPetersen  JAStucka  R  et al.  FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients.  J Med Genet 2004;41 (4) e50PubMed10.1136/jmg.2003.013953Google Scholar
11.
Poppe  MBourke  JEagle  M  et al.  Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I.  Ann Neurol 2004;56 (5) 738- 741PubMedGoogle Scholar
12.
Fougerousse  FDurand  MSuel  L  et al.  Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development.  Genomics 1998;48 (2) 145- 156PubMedGoogle Scholar
13.
Ettinger  AJFeng  GSanes  JR ε-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D.  J Biol Chem 1997;272 (51) 32534- 32538PubMedGoogle Scholar
14.
Duclos  FStraub  VMoore  SA  et al.  Progressive muscular dystrophy in α-sarcoglycan-deficient mice.  J Cell Biol 1998;142 (6) 1461- 1471PubMedGoogle Scholar
15.
Politano  LNigro  VPassamano  L  et al.  Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.  Neuromuscul Disord 2001;11 (2) 178- 185PubMedGoogle Scholar
16.
Fanin  MMelacini  PBoito  CPegoraro  EAngelini  C LGMD2E patients risk developing dilated cardiomyopathy.  Neuromuscul Disord 2003;13 (4) 303- 309PubMedGoogle Scholar
17.
Ben Hamida  MBen Hamida  CZouari  MBelal  SHentati  F Limb-girdle muscular dystrophy 2C: clinical aspects.  Neuromuscul Disord 1996;6 (6) 493- 494PubMedGoogle Scholar
18.
Dinçer  PLeturcq  FRichard  I  et al.  A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey.  Ann Neurol 1997;42 (2) 222- 229PubMedGoogle Scholar
19.
Melacini  PFanin  MDanieli  GA  et al.  Cardiac involvement in Becker muscular dystrophy.  J Am Coll Cardiol 1993;22 (7) 1927- 1934PubMedGoogle Scholar
20.
Duboc  DMeune  CPierre  B  et al.  Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up.  Am Heart J 2007;154 (3) 596- 602PubMedGoogle Scholar
21.
SOLVD Investigators, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.  N Engl J Med 1992;327 (10) 685- 691PubMedGoogle Scholar
Original Contribution
September 2008

Cardiac Involvement in Patients With Limb-Girdle Muscular Dystrophy Type 2 and Becker Muscular Dystrophy

Author Affiliations

Author Affiliations: Neuromuscular Research Unit, Department of Neurology, Copenhagen Muscle Research Center (Drs Sveen and Vissing), and Department of Cardiology, University of Copenhagen, Rigshospitalet (Drs Thune and Køber), Copenhagen, Denmark.

Arch Neurol. 2008;65(9):1196-1201. doi:10.1001/archneur.65.9.1196
Abstract

Objective  To investigate the extent of cardiac involvement in patients with 1 of the 12 groups of recessively inherited limb-girdle muscular dystrophy type 2 (LGMD2A-L) and Becker muscular dystrophy (BMD).

Design  Prospective screening.

Setting  Neuromuscular Clinic and Department of Cardiology at Rigshospitalet.

Patients  One hundred one patients with LGMD2A-I and BMD and 29 patients with LGMD2 and no molecular diagnosis.

Main Outcome Measures  Clinical investigation, echocardiography, and electrocardiographic findings.

Results  Cardiac involvement was present in 24 of 100 patients (24%) with LGMD2A-I and in 14 of 30 patients (47%) with BMD. Only a few patients with LGMD2A and unclassified LGMD2 had mild cardiac involvement, whereas 29% and 67% of patients with LGMD2I and LGMD2E, respectively, had cardiac involvement. Cardiac involvement was not correlated with age, muscle strength, or the level of dystrophic changes on muscle biopsy.

Conclusions  This study demonstrates a high prevalence of cardiac involvement in patients with LGMD2I, LGMD2E, and BMD. Patients with LGMD2A, LGMD2D, and unclassified LGMD2 have a much lower and milder prevalence of cardiac involvement.

×